Identification of ovarian cancer-associated antigens forming complexes with autoantibodies
Open Access
- 7 April 2026
- journal article
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 19 (1)
Abstract
Tumor-associated antigen (Ag)-autoantibody (AAb) complexes are known to be present in the circulation of patients with multiple types of cancer; however, their significance remains poorly understood. We performed immunoblotting of whole cell extracts of the human ovarian cancer cell lines AMOC2, OVCAR3 and SKOV3 with either free antibodies (Abs) or antigen-dissociated Abs obtained from ovarian cancer ascites and healthy sera. In addition, Ag-AAb complexes isolated from ovarian cancer ascites were analyzed by mass spectrometry to identify tumor-associated antigens. Enzyme-linked immunosorbent assay (ELISA) was then used to evaluate the presence of one extracellular matrix (ECM) candidate antigen, SPON1, in its free versus complexed form in ascites and sera. Immunoblotting revealed that tumor-associated AAbs in ovarian cancer ascites predominantly exist in Ag-AAb complexes rather than as free AAbs. Proteomic profiling identified 72 tumor-associated antigens enriched in ovarian cancer ascites compared with healthy and disease control sera; more than half were ECM- or epithelial–mesenchymal transition (EMT)-related proteins. ELISA demonstrated that SPON1 was preferentially detected as Ag-AAb complexes, but not in its free form, in both ascites and sera of ovarian cancer patients. We uncovered that AAbs predominantly form complexes with tumor-associated antigens in ovarian cancer patients. Since the presence of Ag-AAb complexes has been overlooked in many reports, the identification of tumor-associated antigens and AAbs from Ag-AAb complexes would provide novel insights into their relevance to a variety of cancers and other diseases. The online version contains supplementary material available at 10.1186/s13048-026-02089-8.Keywords
Funding Information
- Japan Society for the Promotion of Science (23K08716)
- Japan Society for the Promotion of Science (23K15841)
- The Seiichi Imai Memorial Foundation
This publication has 47 references indexed in Scilit:
- Tumor-reactive antibodies evolve from non-binding and autoreactive precursorsCell, 2022
- Development of autoantibody signatures for common cancersSeminars in Immunology, 2020
- Human epididymis protein 4 antigen‐autoantibody complexes complement cancer antigen 125 for detecting early‐stage ovarian cancerCancer, 2019
- Autoantibodies as diagnostic and prognostic cancer biomarker: Detection techniques and approachesBiosensors and Bioelectronics, 2019
- Autoantibody Production in Cancer—The Humoral Immune Response toward Autologous Antigens in Cancer PatientsAutoimmunity Reviews, 2016
- A systematic review of humoral immune responses against tumor antigensCancer Immunology, Immunotherapy, 2009
- Identifying novel autoantibody signatures in ovarian cancer using high-density protein microarraysClinical Biochemistry, 2009
- Clinical significance of serum and ascitic p53 autoantibodies in epithelial ovarian carcinomaCancer, 2000
- F-spondin: A gene expressed at high levels in the floor plate encodes a secreted protein that promotes neural cell adhesion and neurite extensionCell, 1992
- Isolation of tumor‐specific antibodies from effusions of ovarian carcinomasInternational Journal of Cancer, 1975